International

Asia Pacific

Trinity has been working in the APAC region for over 10 years and has completed over 550 projects related to the region. There are ~20 Trinity experts associated with the Asia Pacific Center of Excellence.

Home / International / Asia Pacific

Trinity supports global and local clients with commercialization strategies in the APAC region, in addition to supporting local clients with global expansion strategies.

We leverage our expertise of APAC markets to develop recommendations and strategies pertinent to local needs.
We bring APAC-specific and evidence-based insights to support our recommendations.
We enhance communication and collaboration across global and APAC teams to ensure local needs are addressed.

Supporting All Commercialization Needs
Corporate & New Product Strategy
- Corporate Strategy
- Business Development
- New Product Planning
Launch & Brand Excellence
- Launch Planning
- Brand Planning
- Strategic Competitive Intelligence
Evidence, Value, Access & Pricing
- Evidence Strategy
- Value, Access & Pricing
Primary & Secondary Insights
- Qualitative and Quantitative Research
Analytics
- Forecasting
Questions We Can Help You Answer
What is our China go-to-market strategy?
- Should we target Tier 1 vs other Tier cities? How should we approach reaching the rural segment?
- How should we consider partnerships / joint ventures with local companies?
- What accelerated commercialization options can I leverage (e.g., Free Trade Zones, breakthrough therapy)?
How should we be organized across different APAC markets?
- What business model would ensure optimal collaboration between global/HQ teams and local affiliates?
- What business model would I need for APAC? Are there ‘archetypes’ across regions?
- How should we invest/partner with local/regional R&D hubs (e.g., China, Singapore)?
- What commercial capabilities do we need to build to remain competitive in the future?
How do we ensure pricing and market access success?
- Is national reimbursement in China still the ‘best option’? How sustainable is a private insurance / cash-pay model?
- What price can we expect in local markets? How should we consider local/regional price referencing?
- What innovative access and reimbursement options could we explore (e.g., hospital reimbursement pathway, Nanbayu, pay-by-installments)
How do I maximize value in local markets?
- What are opportunities to optimize our portfolio to meet local needs (e.g., medical, economic)?
- How should we accelerate global development programs to meet specific needs in APAC?
- What local innovation and business development opportunities should we pursue?
Unique regional capabilities
- Multilingual experts that are fluent in local language (Chinese, Japanese, Korean, etc.) to ensure optimal execution of research programs
- Extensive network of stakeholder types, including KOLs, providers, regulatory experts, payers and patients
- Ability to conduct market research in different formats (in-person, telephone, video platform, central facility, web survey)

Latest Asia Pacific Intelligence

Webinars

2023 NRDL Update: An Ongoing Voyage of Innovation and Accessibility

May 1, 2024 | 12:00 – 12:45 PM ET / 18:00 – 18:45 CET

An additional session will be offered on May 7th at 16:00-16:45 (UTC+8:00) – Asia/Shanghai How can manufacturers strategize for pricing and market access success amidst the evolving landscape of China’s NRDL? As China continues to be a key pharmaceutical market, understanding the latest National Reimbursement Drug List (NRDL) trends and policy evolvement is crucial for […]

Webinars

Annual State of Global Market Access Webinar

Available On Demand

Trinity Life Sciences is pleased to release our highly anticipated white paper, the Annual State of Global Market Access. This year’s white paper focuses on six key global market access trends and provides payer perspectives on these trends. We explore the consequences of new therapeutic advances and policies aiming to control costs globally and the […]

Watch Now

White Papers

2022 NRDL Pricing Implementation and Access Outcomes in China

The pricing and market access (P&MA) landscape in China has been rapidly evolving as the country continuously attempts to balance rewarding innovation and sustainability of healthcare funding. China represents a unique and dynamic market archetype for manufacturers especially in terms of P&MA strategies. China’s aging population (≥60 years) is estimated to exceed 400 million by […]

View All APAC Thought Leadership